[New approaches in the treatment of hepatitis B]

Dtsch Med Wochenschr. 2004 May 21;129(21):1203-8. doi: 10.1055/s-2004-824872.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • 2-Aminopurine / analogs & derivatives*
  • 2-Aminopurine / therapeutic use
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Arabinofuranosyluracil / analogs & derivatives*
  • Arabinofuranosyluracil / therapeutic use
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / prevention & control
  • Contraindications
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Emtricitabine
  • Famciclovir
  • Guanine / analogs & derivatives*
  • Guanine / therapeutic use
  • Hepatitis B, Chronic / complications
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Lamivudine / therapeutic use
  • Liver Neoplasms / mortality
  • Liver Neoplasms / prevention & control
  • Organophosphonates*
  • Organophosphorus Compounds / therapeutic use
  • Polyethylene Glycols / therapeutic use
  • Prodrugs / therapeutic use
  • Prognosis
  • Recombinant Proteins
  • Tenofovir
  • Zalcitabine / analogs & derivatives
  • Zalcitabine / therapeutic use

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Organophosphonates
  • Organophosphorus Compounds
  • Prodrugs
  • Recombinant Proteins
  • Deoxycytidine
  • Lamivudine
  • Arabinofuranosyluracil
  • Polyethylene Glycols
  • 2-Aminopurine
  • entecavir
  • Guanine
  • Zalcitabine
  • Tenofovir
  • Emtricitabine
  • clevudine
  • Adenine
  • dexelvucitabine
  • peginterferon alfa-2a
  • Famciclovir
  • adefovir dipivoxil